Showing 491-500 of 3009 results for "".
A Stop Sign for SSRIs and SNRIs?
https://practicalneurology.com/diseases-diagnoses/headache-pain/a-stop-sign-for-ssris-and-snris/30558/A new analysis sees no role for the drugs for migraine.Updates in Diagnostic Testing in Parkinson Disease
https://practicalneurology.com/diseases-diagnoses/movement-disorders/updates-in-diagnostic-testing-in-parkinson-disease/32164/A review of diagnostic tests for Parkinson disease, including DAT-SPECT, α-synuclein skin biopsy and CSF studies, and genetic testing, offering guidance on their appropriate use and interpretation.Vascular Cognitive Impairment, Part 1
https://practicalneurology.com/diseases-diagnoses/alzheimer-disease-dementias/vascular-cognitive-impairment-part-1/30592/Cognitive impairment after acute stroke is likely under-appreciated despite its impact.Treatment of Seizures in Patients with Significant Drug Interactions and Co-Morbidities
https://practicalneurology.com/diseases-diagnoses/epilepsy-seizures/treatment-of-seizures-in-patients-with-significant-drug-interactions-and-co-morbidities/30637/How can clinicians optimize treatment of seizures for individuals with cardiovascular disease or glioblastoma?Diagnosing Small Fiber Neuropathy Through the Use of Skin Biopsy
https://practicalneurology.com/columns/practice-management/PN1009_06-php/30883/A simple test can easily determine the presence of small fiber neuropathy. Here's what you need to know.Vitamin D: Considerations for Treatment, Prevention, and Risk in Multiple Sclerosis Care
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/vitamin-d-considerations-for-treatment-prevention-and-risk-in-multiple-sclerosis-care/30373/Preliminary signals are strong that vitamin D has a role to play in MS, but more research is needed to confirm the need for supplementation as a preventive or therapeutic measure.Friedreich Ataxia: Pathophysiology and Treatment
https://practicalneurology.com/diseases-diagnoses/movement-disorders/friedreich-ataxia-pathophysiology-and-treatment/32041/Great strides have been made in understanding the pathophysiology of Friedreich ataxia, and a variety of treatments are available, including the first drug approved for Friedreich ataxia treatment in 2023.“It's Not in Your Head”: Navigating the Challenges of a Functional Movement Disorder Diagnosis
https://practicalneurology.com/diseases-diagnoses/movement-disorders/its-not-in-your-head-navigating-the-challenges-of-a-functional-movement-disorder-diagnosis/30384/Epilepsy Essentials: Epilepsy Genetics: What the General Neurologist Needs To Know
https://practicalneurology.com/diseases-diagnoses/epilepsy-seizures/epilepsy-essentials-epilepsy-genetics-what-the-general-neurologist-needs-to-know/30566/Legislative Update: The Future of MACRA
https://practicalneurology.com/columns/practice-management/legislative-update-the-future-of-macra/30329/With a proposed rule change currently under consideration, one expert assesses the impact and the future of the new law.